Mandate

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group

November 21, 2017 EU, Competition and Regulatory

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group HSNG AB (”HSNG”). The seller is Qliro Group AB (publ).

HSNG is a leading actor within e-commerce of health and sport nutrition in the Nordics and runs its business mainly through the internet stores Gymgrossisten.com and Bodystore.com. In addition, Gymgrossisten has physical franchise stores.

Orkla is a leading supplier of branded consumer goods and concept solutions to the grocery, out-of-home and bakery markets in the Nordics, Baltics and selected markets in Central Europe and India. Orkla is listed on the Oslo Stock Exchange and its head office is in Oslo. In 2016, the Group had a turnover of approximately NOK 38 billion, and 18,000 employees at year end.

The transaction is subject to the approval of the relevant competition authorities.

Vinge’s team consists, among others, of responsible partner Peter Sundgren as well as counsel Joacim Rydergård and associates Christina Odengran, Christoffer Nordin, Emelie Håkansson, Mika Jordan, Sara Strandberg, Filip Markhed and Ilze Lukins. Partner Johan Karlsson as well as, among others, associates Trine Osen Bergqvist and Xandra Ståhlberg are advising on competition law issues.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025